SYH2051 tablets

DRUG2 trials

Sponsors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd., CSPC Megalith Biopharmaceutical Co.,Ltd.

Conditions

Advanced Solid TumorsBreast CancerHead and Neck CancerSolid Tumors

Phase 1

A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Head and Neck Cancer, Solid Tumors

Start: 2023-08-15End: 2025-08-31Target: 73Updated: 2023-10-27

Clinical Trial of SYS6010±SYH2051 Versus Chemotherapy in Advanced Breast Cancer and Other Solid Tumors

Not yet recruitingNCT06775236

CSPC Megalith Biopharmaceutical Co.,Ltd.Advanced Solid Tumors, Breast Cancer

Start: 2025-03-20End: 2028-01-15Target: 410Updated: 2025-03-19